Corzo, V. M., Thomas, C., Raab, G. T., Holmes, A. N., Okobi, T. J., Fajardo, A. R., Patel, A., Davidson, Z., Ruder, S. F., Nuzzo, P. V., Yadav, D., Castellanos, S. H., Nanus, D. M., Bander, N. H., Osborne, J. R., Tagawa, S. T. (2025). PSMA-targeted actinium-225 therapy in metastatic castration-resistant prostate cancer (mCRPC): Baseline and follow-up PSMA PET parameters associated with outcomes.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5070